Accelerated vs. conventionally fractionated postoperative radiotherapy of non-small cell lung cancer: final results of the prematurely terminated PORTAF trial

A prolonged overall treatment time (OTT) has been demonstrated to adversely affect the primary radiation therapy (RT) outcome in various solid tumors, including non-small cell lung cancer (NSCLC). Retrospective data from our group suggested an advantage of shorter OTT also for postoperative RT (PORT...

Full description

Saved in:
Bibliographic Details
Main Authors: Bütof, Rebecca (Author) , Koi, Lydia (Author) , Löck, Steffen (Author) , Appold, Steffen (Author) , Drewes, Steffen (Author) , Koschel, Dirk (Author) , Kotzerke, Jörg (Author) , Nestle, Ursula (Author) , Adebahr, Sonja (Author) , Zips, Daniel (Author) , Heinzelmann, Frank (Author) , Hehr, Thomas (Author) , Bucher, Dagmar (Author) , Heide, Jürgen (Author) , Belka, Claus (Author) , Manapov, Farkhad (Author) , Wasilewska-Tesluk, Ewa (Author) , Fleckenstein, Jochen (Author) , Krause, Mechthild (Author) , Troost, Esther G. C. (Author) , Baumann, Michael (Author)
Format: Article (Journal)
Language:English
Published: 15 July 2025
In: Strahlentherapie und Onkologie
Year: 2025, Pages: ?
ISSN:1439-099X
DOI:10.1007/s00066-025-02422-y
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00066-025-02422-y
Get full text
Author Notes:Rebecca Bütof, Lydia Koi, Steffen Löck, Steffen Appold, Steffen Drewes, Dirk Koschel, Jörg Kotzerke, Ursula Nestle, Sonja Adebahr, Daniel Zips, Frank Heinzelmann, Thomas Hehr, Dagmar Bucher, Jürgen Heide, Claus Belka, Farkhad Manapov, Ewa Wasilewska-Tesluk, Jochen Fleckenstein, Mechthild Krause, Esther G.C. Troost, Michael Baumann
Description
Summary:A prolonged overall treatment time (OTT) has been demonstrated to adversely affect the primary radiation therapy (RT) outcome in various solid tumors, including non-small cell lung cancer (NSCLC). Retrospective data from our group suggested an advantage of shorter OTT also for postoperative RT (PORT) in patients with NSCLC. The PORTAF trial (ClinicalTrials.gov: NCT02189967) was initiated to prospectively test this hypothesis.
Item Description:Gesehen am 03.12.2025
Physical Description:Online Resource
ISSN:1439-099X
DOI:10.1007/s00066-025-02422-y